The Filing Desk

Precipio vs Rapid Micro Biosystems

Precipio PRPO · Rapid Micro Biosystems RPID · Life Sciences Tools & Services

Rapid Micro Biosystems reported revenue of $34 million in fiscal 2025, 1.4 times Precipio's $24 million in fiscal 2025. Precipio's revenue grew 29.8% in its latest year, and Rapid Micro Biosystems' grew 19.7%. Precipio had an operating margin of -5.0%, against -141.1% at Rapid Micro Biosystems. Free cash flow was $0 million at Precipio and −$32 million at Rapid Micro Biosystems.

Side by side

PrecipioRapid Micro Biosystems
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$24M$34M
Revenue growth29.8%19.7%
Revenue growth a year, last 5 years31.5%15.9%
Gross margin44.5%—
Operating margin−5.0%−141.1%
Net margin−1.5%−140.3%
Free cash flow$0M−$32M
Free cash flow margin1.5%−95.0%
Return on capital−7.8%−192.8%
Net debt to EBITDA−37.4x—
Dividends and buybacks$0M$0M
Change in diluted share count9.5%2.5%
Last close$18.49$0.74
P/E at the last close——
Insider trades, last 12 months—sold $1.1 million
Piotroski F-score7 of 92 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
PrecipioRapid Micro Biosystems
Operating margin
Percent of revenue
PrecipioRapid Micro Biosystems
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
PrecipioRapid Micro Biosystems

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Precipio and Rapid Micro Biosystems pages.